These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4358998)

  • 21. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D; Bralower M
    Arch Neurol; 1977 Dec; 34(12):756-8. PubMed ID: 145212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease: L-dopa treatment and handwriting area.
    Knopp W; Paulson G; Allen JN; Smeltzer D; Brown FD; Kose W
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):115-25. PubMed ID: 4985489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients].
    Sigwald J; Chomette G; Raymondeaud C
    Sem Hop; 1972 Feb; 48(9):609-24. PubMed ID: 4339429
    [No Abstract]   [Full Text] [Related]  

  • 24. Physostigmine in rigid Huntington's disease.
    Fann WE; Gerber CJ; McKenzie GM
    Confin Neurol; 1973; 35(5):312-5. PubMed ID: 4271422
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of choreatic disorders with thiopropazate (Dartal)].
    Neundörfer B; von Rad M
    Nervenarzt; 1971 Jun; 42(6):330-2. PubMed ID: 4253070
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).
    Hornykiewicz O
    Br Med Bull; 1973 May; 29(2):172-8. PubMed ID: 4356552
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa in treating Parkinsonism.
    O'Doherty DS
    Am Fam Physician; 1971 Nov; 4(5):95-9. PubMed ID: 5117507
    [No Abstract]   [Full Text] [Related]  

  • 29. Levodopa therapy in athetoid cerebral palsy. A preliminary report.
    Rosenthal RK; McDowell FH; Cooper W
    Neurology; 1972 Jan; 22(1):1-11. PubMed ID: 4550498
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of choreic hyperkinesias with thioproperazine (Majeptil)].
    Joncev V; Mitkov V
    Folia Med (Plovdiv); 1971; 13(6):339-44. PubMed ID: 4401862
    [No Abstract]   [Full Text] [Related]  

  • 31. Predicting the response to levodopa.
    Van Woert MH; Weintraub MI
    Lancet; 1971 May; 1(7707):1015-6. PubMed ID: 4102426
    [No Abstract]   [Full Text] [Related]  

  • 32. Parkinson's disease and levodopa. A five-year follow-up and review.
    Markham CH; Treciokas LJ; Diamond SG
    West J Med; 1974 Sep; 121(3):188-206. PubMed ID: 4606887
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of Huntington's chorea with lithium carbonate. A double-blind trial.
    Aminoff MJ; Marshall J
    Lancet; 1974 Jan; 1(7848):107-9. PubMed ID: 4130308
    [No Abstract]   [Full Text] [Related]  

  • 34. Biochemical and pharmacological aspects of Parkinsonism.
    Carlsson A
    Acta Neurol Scand Suppl; 1972; 51():11-42. PubMed ID: 4351191
    [No Abstract]   [Full Text] [Related]  

  • 35. "On-off" syndrome treated with lithium carbonate: a case report.
    Ross DR; Coffey CE; Ferren EL; Walker JI; Olanow CW
    Am J Psychiatry; 1981 Dec; 138(12):1626-7. PubMed ID: 6795945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 37. An evaluation of the permanence of the "tardive dyskinesias".
    Paulson GW
    Dis Nerv Syst; 1968 Oct; 29(10):692-4. PubMed ID: 5717285
    [No Abstract]   [Full Text] [Related]  

  • 38. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 40. Levodopa in Huntington's chorea.
    Tan BK; Leijnse-Ybema HJ; v d Brand HJ
    Lancet; 1972 Apr; 1(7756):903. PubMed ID: 4111857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.